Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-08-12ERAS3Insider Filing for Charles S. Fuchs
This filing reports initial beneficial ownership of securities for Charles S. Fuchs, President of R&D at Erasca, Inc. (ERAS). Mr. Fuchs has reported that he does not own any securities as of August 10, 2026. This is an initial filing, indicated by document type '3'....
Mid CapBiotechnology
2026-08-12AURA3Power of Attorney FilingMEDIUM
This filing pertains to a Power of Attorney granted by Erica Kratz, Chief Reg. & Quality Officer of Aura Biosciences, Inc., to Conor Kilroy and Amy Elazzouzi. The power of attorney authorizes the appointees to act on behalf of Ms. Kratz in all matters related to the filing of SEC reports, including Forms 3, 4, and 5, c...
Small CapBiotechnology
2026-08-12AURA3Power of Attorney for Julie Person
This filing is a Power of Attorney granted by Julie Person, Chief People Officer of Aura Biosciences, Inc., to Conor Kilroy and Amy Elazzouzi. The attorneys-in-fact are authorized to act on behalf of Ms. Person regarding the filing of SEC reports (Forms 3, 4, and 5), voluntary filings, electronic filing code requests, ...
Small CapBiotechnology